1h Free Analyst Time
The Obesity Surgery Devices Market grew from USD 4.07 billion in 2023 to USD 4.39 billion in 2024. It is expected to continue growing at a CAGR of 7.91%, reaching USD 6.94 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
The scope of obesity surgery devices encompasses equipment and accessories used to facilitate bariatric surgeries such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding. These devices play a crucial role in the medical sector by addressing obesity - a chronic condition linked to complications like diabetes, cardiovascular diseases, and hypertension. The necessity for these devices is underscored by rising obesity rates globally, driven by unhealthy lifestyles, lack of physical activity, and genetic predispositions. They are primarily used in surgical settings within hospitals and outpatient surgical centers. Key growth factors for this market include increasing obesity prevalence, rising healthcare expenditures, advancements in minimally invasive surgical techniques, and supportive government initiatives promoting weight-loss surgeries. A notable opportunity is the untapped market in emerging economies where healthcare infrastructure is rapidly developing, and awareness is increasing. Companies can capitalize on this by focusing on cutting-edge technologies, such as robotic surgery devices and improved laparoscopic tools. Despite potential growth, the market faces limitations, including high costs of surgery, stringent regulatory frameworks, and a lack of awareness, particularly in less developed regions. There's also a risk of post-surgical complications which could deter adoption. Challenging factors include the variability in reimbursement scenarios across regions, and cultural and psychological barriers to opting for surgical intervention. Innovative research can explore the development of more affordable, safer devices with enhanced efficacy. There is also potential in AI-driven surgery assistance tools and customized patient-centered solutions. The obesity surgery device market is thus evolving, characterized by strong competition among industry players and ongoing technological advancements. Firms must focus on strategic partnerships, scaling innovation, and addressing regulatory requirements to drive growth. A deep understanding of patient needs and market dynamics will be essential for capturing potential opportunities in this expanding market sector.
Understanding Market Dynamics in the Obesity Surgery Devices Market
The Obesity Surgery Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Prevalence of obese population worldwide
- Growing awareness regarding weight management and fitness
- Growing number of bariatric surgeries and minimally invasive procedures
- Market Restraints
- Product recall and high cost of advanced surgery devices
- Market Opportunities
- Technological advancements in obesity surgery devices
- Rise of medical tourism worldwide
- Market Challenges
- Associated risks, complications and side effects of surgery
Exploring Porter’s Five Forces for the Obesity Surgery Devices Market
Porter’s Five Forces framework further strengthens the insights of the Obesity Surgery Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Obesity Surgery Devices Market
External macro-environmental factors deeply influence the performance of the Obesity Surgery Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Obesity Surgery Devices Market
The Obesity Surgery Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Obesity Surgery Devices Market
The Obesity Surgery Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Obesity Surgery Devices Market
The Obesity Surgery Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Obesity Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Agency for Medical Innovation, Allergan Inc. by AbbVie Inc., Apollo Endosurgery, Inc., B. Braun Melsungen AG, Bariatec Corporation, Cousin Biotech, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic PLC, Olympus Corporation, ReShape Lifesciences, Inc., Spatz FGIA, Inc., Standard Bariatrics, Inc., Stryker Corporation, and TransEnterix Surgical, Inc..Market Segmentation & Coverage
This research report categorizes the Obesity Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:- Type
- Minimally Invasive Surgical Devices
- Accessories
- Stapling Devices
- Suturing Devices
- Non-Invasive Surgical Devices
- Minimally Invasive Surgical Devices
- Procedure
- Adjustable Gastric Banding
- Biliopancreatic Diversion with Duodenal Switch
- Gastric Bypass
- Mini-Gastric Bypass
- Non-Invasive Bariatric Surgery
- Revision Bariatric Surgery
- Sleeve Gastrectomy
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Obesity Surgery Devices Market, by Type
7. Obesity Surgery Devices Market, by Procedure
8. Americas Obesity Surgery Devices Market
9. Asia-Pacific Obesity Surgery Devices Market
10. Europe, Middle East & Africa Obesity Surgery Devices Market
11. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Obesity Surgery Devices Market, which are profiled in this report, include:- Agency for Medical Innovation
- Allergan Inc. by AbbVie Inc.
- Apollo Endosurgery, Inc.
- B. Braun Melsungen AG
- Bariatec Corporation
- Cousin Biotech
- Intuitive Surgical Inc.
- Johnson & Johnson Services Inc.
- Medtronic PLC
- Olympus Corporation
- ReShape Lifesciences, Inc.
- Spatz FGIA, Inc.
- Standard Bariatrics, Inc.
- Stryker Corporation
- TransEnterix Surgical, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 187 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 4.39 Billion |
| Forecasted Market Value ( USD | $ 6.94 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
